Selective androgen receptor modulator has anti-tumor effects in ER-positive breast cancer patients

End­points News dug in­to this week’s earn­ings calls to gath­er bio­phar­ma man­u­fac­tur­ing up­dates. We found that Mod­er­na is cut­ting its man­u­fac­tur­ing ac­tiv­i­ties, while Am­gen pro­vid­ed

Note that some links may require registration or subscription. Prosecutors are seeking the death penalty in the case of a Florida plastic surgeon accused of